News
In this video, Susana M. Campos, MD, MPH, discusses results from a phase 2 trial of pembrolizumab and lenvatinib for patients with recurrent or persistent clear-cell ovarian cancer.Findings from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback